Seagen Inc. - FORM 10-K/A - EX-31.4 - SECTION 302 CFO CERTIFICATION - November 26, 2010

Attached files

file	filename
10-K/A - FORM 10-K AMENDMENT NO. 1 - Seagen Inc.	d10ka.htm
EX-10.7 - AMENDMENT NO. 1 TO THE UNIVERSITY OF MIAMI LICENSE AGREEMENT - Seagen Inc.	dex107.htm
EX-10.6 - LICENSE AGREEMENT DATED SEPTEMBER 20, 1999 - Seagen Inc.	dex106.htm
EX-10.1 - LICENSE AGREEMENT DATED MARCH 30, 1998 - Seagen Inc.	dex101.htm
EX-31.3 - SECTION 302 CEO CERTIFICATION - Seagen Inc.	dex313.htm
EX-10.4 - LICENSE AGREEMENT DATED JUNE 14, 1998 - Seagen Inc.	dex104.htm
EX-10.2 - AMENDMENT LETTER TO THE BRISTOL-MYERS SQUIBB COMPANY LICENSE AGREEMENT - Seagen Inc.	dex102.htm
EX-10.8 - LICENSE AGREEMENT DATED FEBRUARY 3, 2000 - Seagen Inc.	dex108.htm
EX-10.45 - NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN SEATTLE GENETICS, INC. AND ICOS CORP. - Seagen Inc.	dex1045.htm
EX-10.5 - FIRST AMENDMENT TO THE MABTECH LICENSE AGREEMENT DATED JANUARY 31, 2000 - Seagen Inc.	dex105.htm

Exhibit 31.4

CERTIFICATIONS

I, Todd E. Simpson, certify that:

1.	I have reviewed this Amendment No. 1 to Annual Report on Form 10-K/A of Seattle Genetics, Inc.; and

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: November 26, 2010

/S/ TODD E. SIMPSON

Todd E. Simpson

Chief Financial Officer